Erythropoietin and neuroprotection: a therapeutic perspective (Q36440618)

14 August 2017

1 reference

title

Erythropoietin and neuroprotection: a therapeutic perspective (English)

1 reference

14 August 2017

1 reference

Milano M

1

1 reference

14 August 2017

Collomp R

series ordinal

2

1 reference

14 August 2017

publication date

1 December 2005

1 reference

Journal of Oncology Pharmacy Practice

14 August 2017

published in

1 reference

14 August 2017

volume

11

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

145-149

1 reference

Erythropoietin: physiologic and pharmacologic aspects

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

Human recombinant erythropoietin and quality of life: a wonder drug or something to wonder about?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

Impact of epoetin beta on quality of life in patients with malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

What is the effect of systemic anticancer treatment on cognitive function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

Regulated human erythropoietin receptor expression in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

Immunohistochemical localization of erythropoietin and its receptor in the developing human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

The human erythropoietin receptor gene rescues erythropoiesis and developmental defects in the erythropoietin receptor null mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

Erythropoietin and the brain: from neurodevelopment to neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

Erythropoietin and erythropoietin receptor in the developing human central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

A potential role for erythropoietin in focal permanent cerebral ischemia in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

The pleiotropic effects of erythropoietin in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

Erythropoietin and the hypoxic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

Erytropoietin concentrations in cerebrospinal fluid of nonhuman primates and fetal sheep following high-dose recombinant erythropoietin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

A novel protective effect of erythropoietin in the infarcted heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

The cardiovascular effects of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

Derivatives of erythropoietin that are tissue protective but not erythropoietic

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1078155205JP162OA

10.1191/1078155205JP162OA

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference